Cargando…

A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease

OBJECTIVE: FAP plays a vital role in myocardial injury and fibrosis. Although initially used to study imaging of primary and metastatic tumors, the use of FAPI tracers has recently been studied in cardiac remodeling after myocardial infarction. The study aimed to investigate the application of FAPI...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Zhehao, Han, Wei, Zhao, Hongyue, Jiao, Yuying, Xu, Peng, Wang, Yangyang, Shen, Qiuyi, Yang, Shuai, Zhao, Changjiu, Tian, Lin, Fu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441604/
https://www.ncbi.nlm.nih.gov/pubmed/36072860
http://dx.doi.org/10.3389/fcvm.2022.921724
_version_ 1784782616265752576
author Lyu, Zhehao
Han, Wei
Zhao, Hongyue
Jiao, Yuying
Xu, Peng
Wang, Yangyang
Shen, Qiuyi
Yang, Shuai
Zhao, Changjiu
Tian, Lin
Fu, Peng
author_facet Lyu, Zhehao
Han, Wei
Zhao, Hongyue
Jiao, Yuying
Xu, Peng
Wang, Yangyang
Shen, Qiuyi
Yang, Shuai
Zhao, Changjiu
Tian, Lin
Fu, Peng
author_sort Lyu, Zhehao
collection PubMed
description OBJECTIVE: FAP plays a vital role in myocardial injury and fibrosis. Although initially used to study imaging of primary and metastatic tumors, the use of FAPI tracers has recently been studied in cardiac remodeling after myocardial infarction. The study aimed to investigate the application of FAPI PET/CT imaging in human myocardial fibrosis and its relationship with clinical factors. MATERIALS AND METHODS: Retrospective analysis of FAPI PET/CT scans of twenty-one oncological patients from 05/2021 to 03/2022 with visual uptake of FAPI in the myocardium were applying the American Heart Association 17-segment model of the left ventricle. The patients’ general data, echocardiography, and laboratory examination results were collected, and the correlation between PET imaging data and the above data was analyzed. Linear regression models, Kendall’s TaU-B test, the Spearman test, and the Mann–Whitney U test were used for the statistical analysis. RESULTS: 21 patients (60.1 ± 9.4 years; 17 men) were evaluated with an overall mean LVEF of 59.3 ± 5.4%. The calcific plaque burden of LAD, LCX, and RCA are 14 (66.7%), 12 (57.1%), and 9 (42.9%). High left ventricular SUVmax correlated with BMI (P < 0.05) and blood glucose level (P < 0.05), and TBR correlated with age (P < 0.05). A strong correlation was demonstrated between SUVmean and CTnImax (r = 0.711, P < 0.01). Negative correlation of SUVmean and LVEF (r = −0.61, P < 0.01), SUVmax and LVEF (r = −0.65, P < 0.01) were found. ROC curve for predicting calcified plaques by myocardial FAPI uptake (SUVmean) in LAD, LCX, and RCA territory showed AUCs were 0.786, 0.759, and 0.769. CONCLUSION: FAPI PET/CT scans might be used as a new potential method to evaluate cardiac fibrosis to help patients’ management further. FAPI PET imaging can reflect the process of myocardial fibrosis. High FAPI uptakes correlate with cardiovascular risk factors and the distribution of coronary plaques.
format Online
Article
Text
id pubmed-9441604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94416042022-09-06 A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease Lyu, Zhehao Han, Wei Zhao, Hongyue Jiao, Yuying Xu, Peng Wang, Yangyang Shen, Qiuyi Yang, Shuai Zhao, Changjiu Tian, Lin Fu, Peng Front Cardiovasc Med Cardiovascular Medicine OBJECTIVE: FAP plays a vital role in myocardial injury and fibrosis. Although initially used to study imaging of primary and metastatic tumors, the use of FAPI tracers has recently been studied in cardiac remodeling after myocardial infarction. The study aimed to investigate the application of FAPI PET/CT imaging in human myocardial fibrosis and its relationship with clinical factors. MATERIALS AND METHODS: Retrospective analysis of FAPI PET/CT scans of twenty-one oncological patients from 05/2021 to 03/2022 with visual uptake of FAPI in the myocardium were applying the American Heart Association 17-segment model of the left ventricle. The patients’ general data, echocardiography, and laboratory examination results were collected, and the correlation between PET imaging data and the above data was analyzed. Linear regression models, Kendall’s TaU-B test, the Spearman test, and the Mann–Whitney U test were used for the statistical analysis. RESULTS: 21 patients (60.1 ± 9.4 years; 17 men) were evaluated with an overall mean LVEF of 59.3 ± 5.4%. The calcific plaque burden of LAD, LCX, and RCA are 14 (66.7%), 12 (57.1%), and 9 (42.9%). High left ventricular SUVmax correlated with BMI (P < 0.05) and blood glucose level (P < 0.05), and TBR correlated with age (P < 0.05). A strong correlation was demonstrated between SUVmean and CTnImax (r = 0.711, P < 0.01). Negative correlation of SUVmean and LVEF (r = −0.61, P < 0.01), SUVmax and LVEF (r = −0.65, P < 0.01) were found. ROC curve for predicting calcified plaques by myocardial FAPI uptake (SUVmean) in LAD, LCX, and RCA territory showed AUCs were 0.786, 0.759, and 0.769. CONCLUSION: FAPI PET/CT scans might be used as a new potential method to evaluate cardiac fibrosis to help patients’ management further. FAPI PET imaging can reflect the process of myocardial fibrosis. High FAPI uptakes correlate with cardiovascular risk factors and the distribution of coronary plaques. Frontiers Media S.A. 2022-08-22 /pmc/articles/PMC9441604/ /pubmed/36072860 http://dx.doi.org/10.3389/fcvm.2022.921724 Text en Copyright © 2022 Lyu, Han, Zhao, Jiao, Xu, Wang, Shen, Yang, Zhao, Tian and Fu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Lyu, Zhehao
Han, Wei
Zhao, Hongyue
Jiao, Yuying
Xu, Peng
Wang, Yangyang
Shen, Qiuyi
Yang, Shuai
Zhao, Changjiu
Tian, Lin
Fu, Peng
A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
title A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
title_full A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
title_fullStr A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
title_full_unstemmed A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
title_short A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
title_sort clinical study on relationship between visualization of cardiac fibroblast activation protein activity by al(18)f-nota-fapi-04 positron emission tomography and cardiovascular disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441604/
https://www.ncbi.nlm.nih.gov/pubmed/36072860
http://dx.doi.org/10.3389/fcvm.2022.921724
work_keys_str_mv AT lyuzhehao aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT hanwei aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT zhaohongyue aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT jiaoyuying aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT xupeng aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT wangyangyang aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT shenqiuyi aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT yangshuai aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT zhaochangjiu aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT tianlin aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT fupeng aclinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT lyuzhehao clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT hanwei clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT zhaohongyue clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT jiaoyuying clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT xupeng clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT wangyangyang clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT shenqiuyi clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT yangshuai clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT zhaochangjiu clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT tianlin clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease
AT fupeng clinicalstudyonrelationshipbetweenvisualizationofcardiacfibroblastactivationproteinactivitybyal18fnotafapi04positronemissiontomographyandcardiovasculardisease